NCT04412785
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Coronaviridae Infections
Explore clinical trials studying Coronaviridae Infections. Study availability and eligibility vary by location and protocol.
5,124 public trials
293 recruiting studies
Coronaviridae Infections trial results
NCT05069662
- Conditions
- COVID-19, Cancer, Coronaviridae Infections, +11 more
- Locations
-
- Service Pharmaceutique, Hospices Civils de Lyon Pierre-Bénite, France
NCT04602312
- Conditions
- COVID-19, Catastrophizing Coronavirus (COVID-19), Coronaviridae Infections, +10 more
- Locations
-
- Health and Behavioural Sciences Brisbane, Queensland, Australia
NCT05185804
- Conditions
- COVID-19, Cardiovascular Diseases, Coronaviridae Infections, +18 more
- Locations
-
- Regional budgetary healthcare institution Ivanovskaya clinical hospital named after Kuvaevs Ivanovo, Russia
- State Budgetary Institution of Healthcare Research Institute - Regional Clinical Hospital No. 1 named after Professor S.V. Ochapov Ministry of Health of the Krasnodar Territory Krasnodar, Russia
- Federal State Budgetary Educational Institution of Higher Education Ryazan State Medical University named after academician I.P. Pavlova of the Ministry of Health of the Russian Federation Ryazan, Russia
- State Healthcare Institution Saratov City Clinical Hospital No. 2 named after IN AND. Razumovsky Saratov, Russia
NCT04354584
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
- Locations
-
- Dept. of Intensive Care 542, University Hospital Hvidovre Hvidovre, Copenhagen, Denmark
Completed
Antibody After COVID-19 Vaccination
NCT05057936
- Conditions
- Breakthrough Infection, Breakthrough Infections, CKD, +27 more
- Locations
-
- Faculty of Medicine,Vajira Hospital Bangkok, Thailand
NCT05143333
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- Johns Hopkins Psychiatry department Baltimore, Maryland, United States
Completed
Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19
NCT05184127
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- NRC Institute of Immunology FMBA Moscow, Russia
NCT04503525
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +13 more
- Locations
-
- Saint-Vincent Hospital Lille, Haut-de-France, France
NCT04501432
- Conditions
- Behavior, COVID-19, Cardiac Rehabilitation, +12 more
- Locations
-
- Institute of Sports Medicine, Prevention and Rehabilitation Salzburg, Austria